In breast cancers, Nav1.5 α subunit mRNA and protein expression correlates with metastatic potential, and the neonatal SCN5A splice variant is expressed ~1,800-fold higher in metastatic MDA-MB-231 cells than in weakly metastatic MCF-7 cells. Here, SCN5A is linked to breast cancer.